Documentation is available at https://posebusters.readthedocs.io. For more information about the tests and for a study using PoseBusters to compare docking methods, refer to our paper or preprint: ...

The report covers drug details, clinical trials, and treatment strategies, emphasizing innovative approaches for CIA managementDublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Anemia ...

Credit: Quality Stock Arts/Shutterstock. Modular energy storage and power quality solutions provider SINEXCEL has entered a strategic partnership with Molecule Systems to deliver an integrated energy ...

Molecule Software has been recognized for its groundbreaking advancements in energy trading and risk management (ETRM) Software for power and renewables trading, earning two Innovation awards in the ...

A molecule named NM102 selectively inhibits the Mfd protein, a bacterial virulence and mutation factor, thereby disarming pathogenic bacteria without affecting beneficial microbiota.

and this change was accompanied by the presence of the microbial molecule ADP-heptose in the bloodstream (Fig. 1). ADP-heptose is notable because of its ability to stimulate immune responses ...

A new study shows that the synthetic molecule CPMAC, developed from buckminsterfullerene (C₆₀), significantly improves the energy efficiency and durability of perovskite solar cells. By forming ...

High-dose erythropoietin did not improve outcomes for infants with hypoxic ischemic encephalopathy. Controlled cooling within 6 hours of birth remains the best treatment for birth asphyxia.

Although the work was completed in mice, there are strong indications that the protein, erythropoietin or EPO ... the effect on cancer growth of a common immunotherapy targeting a molecule called PD-1 ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study.

Stanford University scientists have found that erythropoietin (EPO), a protein ... cancer growth of a common immunotherapy targeting a molecule called PD-1 on immune cells called T cells.